Benefits
Gentle chelated copper source
Binding copper to glycine produces a near-neutral, well-tolerated complex that is easy to formulate in clean-label products. Copper bisglycinate is a practical way to meet copper needs and to balance copper against supplemental zinc.
Supports antioxidant defense
Copper is essential for copper-zinc superoxide dismutase, an antioxidant enzyme that neutralizes superoxide radicals. Adequate copper status supports this enzyme and the body's broader defense against oxidative stress.
Supports healthy red blood cells
Copper-dependent ceruloplasmin is needed for normal iron transport and red blood cell formation. Maintaining adequate copper helps support healthy blood, particularly in people taking zinc that can deplete copper.
Supports connective tissue
Copper activates lysyl oxidase, which cross-links collagen and elastin in skin, bone, and blood vessels. Adequate copper helps maintain the integrity and elasticity of connective tissue throughout the body.
Balances supplemental zinc
Because high-dose zinc depletes copper over time, copper bisglycinate is commonly included in zinc-containing immune formulas to maintain a healthy zinc-to-copper ratio and prevent copper deficiency.
Mechanism of action
Glycine chelation chemistry
Two glycine molecules coordinate the copper ion through amino and carboxyl groups, forming a stable ring complex. Proponents claim this protects copper from dietary antagonists, but controlled human absorption comparisons supporting a real-world advantage are lacking.
Cu/Zn-SOD antioxidant activity
Once absorbed, copper occupies the active site of copper-zinc superoxide dismutase, enabling conversion of superoxide radicals to hydrogen peroxide and protecting cells from oxidative damage.
Ceruloplasmin and iron handling
Copper incorporated into ceruloplasmin supports its ferroxidase activity, which is required for iron loading onto transferrin and normal red blood cell production, linking copper status to healthy blood.
Regulated intestinal uptake
Copper from chelates and salts alike is absorbed via the CTR1 transporter and is homeostatically regulated, with fractional absorption decreasing as intake rises. This regulation tends to blunt formulation-based absorption differences.
Clinical trials
Controlled bioavailability study comparing organic copper bis-glycinate with inorganic copper sulfate in beef steers fed a high-antagonist diet, using liver and plasma copper as endpoints.
Beef steers (high-antagonist diet).
Relative bioavailability of copper bis-glycinate was about 82% of copper sulfate based on liver copper, with no significant difference based on plasma copper. CRITICAL FRAMING: the chelate was not superior and was somewhat lower by liver copper, undercutting the high-absorption marketing claim. No human head-to-head trials exist.
Stable-isotope (65Cu) metabolic study measuring copper absorption and retention in young men across low, adequate, and high copper intakes.
11 young men.
Copper absorption was high at low intake and low at high intake, demonstrating tight homeostatic control of copper uptake. Because absorption is regulated by body status, the form of copper has limited ability to alter overall copper retention in replete individuals.